Pharmaceutical company Ratio Therapeutics appointed Jacob Hesterman, PhD, as its new chief data officer.
Before joining Ratio Therapeutics, Dr. Hesterman was chief technology officer at radiology and imaging company Invirco. He eventually became CTO at Invirco's parent company, Realm IDx, according to a Sept. 15 news release from Ratio Therapeutics.
"I believe the team at Ratio is applying cutting-edge science and technology to the development of their radiotherapeutics and I am delighted to join Ratio's world-class co-founders, John Hoppin, PhD, and Jack Babich, PhD, in their commitment to developing effective treatments for cancer patients," Dr. Hesterman said in the release.